Literature DB >> 14592199

Narcolepsy and psychopathology: is there an association?

A Vourdas1, J M Shneerson, C A Gregory, I E Smith, M A King, E Morrish, P J McKenna.   

Abstract

BACKGROUND: It is widely believed that patients with narcolepsy show high rates of associated psychiatric disturbance, especially schizophrenia and depression. However, surveys have produced conflicting findings and have not addressed the potential confounding effects of stimulant drug treatment.
METHOD: Forty-five patients with narcolepsy attending a sleep disorder clinic and 50 matched normal controls underwent structured psychiatric interview. Using a 'lifetime' approach, psychiatric symptoms and diagnoses were established for both groups.
RESULTS: Four of the narcolepsy patients but none of the controls had experienced psychotic symptoms. All four patients were taking amphetamines, and the symptoms resolved when the dose was lowered or treatment was changed to modafinil. The lifetime frequency of various depressive syndromes did not differ significantly between the groups.
CONCLUSIONS: Contrary to previous claims this study found little to suggest that narcolepsy is associated with schizophrenia. Nor, despite its serious social and occupational consequences, does narcolepsy appear to be associated with an increased frequency of diagnosable depressive disorders.

Entities:  

Year:  2002        PMID: 14592199     DOI: 10.1016/s1389-9457(02)00062-x

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  14 in total

Review 1.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

2.  Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.

Authors:  Francesca Letizia Rocca; Elena Finotti; Fabio Pizza; Francesca Ingravallo; Michela Gatta; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

3.  Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent, Arvicanthis niloticus.

Authors:  Widya Adidharma; Sean P Deats; Tomoko Ikeno; Jack W Lipton; Joseph S Lonstein; Lily Yan
Journal:  Horm Behav       Date:  2019-08-31       Impact factor: 3.587

4.  Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Authors:  Francesca Canellas; Ling Lin; Maria Rosa Julià; Antonio Clemente; Cristofol Vives-Bauza; Hanna M Ollila; Seung Chul Hong; Susana M Arboleya; Mali A Einen; Juliette Faraco; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

Review 5.  Hypersomnolence, Hypersomnia, and Mood Disorders.

Authors:  Lucie Barateau; Régis Lopez; Jean Arthur Micoulaud Franchi; Yves Dauvilliers
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

Review 6.  The hypocretin system and psychiatric disorders.

Authors:  Fabio Pizza; Michele Magnani; Camilla Indrio; Giuseppe Plazzi
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

Review 7.  Unusual sleep experiences, dissociation, and schizotypy: Evidence for a common domain.

Authors:  Erin Koffel; David Watson
Journal:  Clin Psychol Rev       Date:  2009-06-21

8.  Complex diagnostic and treatment issues in psychotic symptoms associated with narcolepsy.

Authors:  Sricharan Moturi; Anna Ivanenko
Journal:  Psychiatry (Edgmont)       Date:  2009-06

Review 9.  Interactions of the histamine and hypocretin systems in CNS disorders.

Authors:  Ling Shan; Yves Dauvilliers; Jerome M Siegel
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 10.  Hypersomnia and depressive symptoms: methodological and clinical aspects.

Authors:  Yves Dauvilliers; Régis Lopez; Maurice Ohayon; Sophie Bayard
Journal:  BMC Med       Date:  2013-03-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.